Ashley M Nassiri, Kelly Staricha, Brian A Neff, Colin L W Driscoll, Michael J Link, Matthew L Carlson
{"title":"散发性内耳室管膜瘤患者同时接受和未接受肿瘤切除术的人工耳蜗植入疗效。","authors":"Ashley M Nassiri, Kelly Staricha, Brian A Neff, Colin L W Driscoll, Michael J Link, Matthew L Carlson","doi":"10.1097/MAO.0000000000004268","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>Describe a single institution's cochlear implant outcomes for patients with inner ear schwannomas (IES) in the setting of various tumor management strategies (observation, surgical resection, or stereotactic radiosurgery [SRS]).</p><p><strong>Study design: </strong>Single-institution retrospective review.</p><p><strong>Patients: </strong>Patients diagnosed with isolated, sporadic IES who underwent cochlear implantation (CI).</p><p><strong>Interventions: </strong>CI with or without IES treatment.</p><p><strong>Main outcome measures: </strong>Speech perception outcomes, tumor status.</p><p><strong>Results: </strong>Twelve patients with IES underwent CI with a median audiologic and radiologic follow-up of 12 months. Six patients underwent complete resection of the tumor at the time of CI, four underwent tumor observation, and two underwent SRS before CI. At 1 year after CI for all patients, the median consonant-nucleus-consonant (CNC) word score was 55% (interquartile range, 44-73%), and the median AzBio sentence in quiet score was 77% (interquartile range, 68-93%). Overall, those with surgical resection performed similarly to those with tumor observation (CNC 58 versus 61%; AzBio in quiet 74 versus 91%, respectively). Patients who underwent tumor resection before implantation had a wider range of speech performance outcomes compared with patients who underwent tumor observation. Two patients had SRS treatment before CI (10 months previous and same-day as CI) with CNC word scores of 6 and 40%, respectively.</p><p><strong>Conclusions: </strong>Patients with IES who underwent CI demonstrated similar speech performance outcomes (CNC 56% and AzBio 82%), when compared with the general cochlear implant population. Patients who underwent either tumor observation or surgical resection performed well after CI.</p>","PeriodicalId":19732,"journal":{"name":"Otology & Neurotology","volume":" ","pages":"1051-1054"},"PeriodicalIF":1.9000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Cochlear Implantation Outcomes in Patients With Sporadic Inner Ear Schwannomas With and Without Simultaneous Tumor Resection.\",\"authors\":\"Ashley M Nassiri, Kelly Staricha, Brian A Neff, Colin L W Driscoll, Michael J Link, Matthew L Carlson\",\"doi\":\"10.1097/MAO.0000000000004268\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objectives: </strong>Describe a single institution's cochlear implant outcomes for patients with inner ear schwannomas (IES) in the setting of various tumor management strategies (observation, surgical resection, or stereotactic radiosurgery [SRS]).</p><p><strong>Study design: </strong>Single-institution retrospective review.</p><p><strong>Patients: </strong>Patients diagnosed with isolated, sporadic IES who underwent cochlear implantation (CI).</p><p><strong>Interventions: </strong>CI with or without IES treatment.</p><p><strong>Main outcome measures: </strong>Speech perception outcomes, tumor status.</p><p><strong>Results: </strong>Twelve patients with IES underwent CI with a median audiologic and radiologic follow-up of 12 months. Six patients underwent complete resection of the tumor at the time of CI, four underwent tumor observation, and two underwent SRS before CI. At 1 year after CI for all patients, the median consonant-nucleus-consonant (CNC) word score was 55% (interquartile range, 44-73%), and the median AzBio sentence in quiet score was 77% (interquartile range, 68-93%). Overall, those with surgical resection performed similarly to those with tumor observation (CNC 58 versus 61%; AzBio in quiet 74 versus 91%, respectively). Patients who underwent tumor resection before implantation had a wider range of speech performance outcomes compared with patients who underwent tumor observation. Two patients had SRS treatment before CI (10 months previous and same-day as CI) with CNC word scores of 6 and 40%, respectively.</p><p><strong>Conclusions: </strong>Patients with IES who underwent CI demonstrated similar speech performance outcomes (CNC 56% and AzBio 82%), when compared with the general cochlear implant population. Patients who underwent either tumor observation or surgical resection performed well after CI.</p>\",\"PeriodicalId\":19732,\"journal\":{\"name\":\"Otology & Neurotology\",\"volume\":\" \",\"pages\":\"1051-1054\"},\"PeriodicalIF\":1.9000,\"publicationDate\":\"2024-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Otology & Neurotology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1097/MAO.0000000000004268\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/8/5 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q3\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Otology & Neurotology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/MAO.0000000000004268","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/8/5 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
摘要
目标:描述一家医疗机构在采用不同肿瘤治疗策略(观察、手术切除或立体定向放射外科手术 [SRS])的情况下,为内耳分裂瘤(IES)患者植入人工耳蜗的效果:患者:患者:诊断为孤立性、散发性 IES 并接受人工耳蜗植入术(CI)的患者:主要结果指标:语音感知结果、肿瘤状态:结果:12 名 IES 患者接受了人工耳蜗植入术:12名IES患者接受了CI,中位听力和放射学随访时间为12个月。6 名患者在 CI 时接受了肿瘤完全切除术,4 名患者接受了肿瘤观察,2 名患者在 CI 前接受了 SRS。所有患者在接受 CI 治疗 1 年后,辅音-核-共音(CNC)单词得分的中位数为 55%(四分位间范围为 44-73%),AzBio 句子安静得分的中位数为 77%(四分位间范围为 68-93%)。总体而言,接受手术切除的患者与接受肿瘤观察的患者表现相似(CNC 58% 对 61%;AzBio 安静句子得分率分别为 74% 对 91%)。与接受肿瘤观察的患者相比,在植入前接受肿瘤切除术的患者的语言表达结果范围更广。两名患者在 CI 前接受了 SRS 治疗(10 个月前和 CI 当天),CNC 单词得分分别为 6 分和 40%:结论:与普通人工耳蜗植入患者相比,接受 CI 的 IES 患者表现出相似的语言能力(CNC 56% 和 AzBio 82%)。接受肿瘤观察或手术切除的患者在 CI 后表现良好。
Cochlear Implantation Outcomes in Patients With Sporadic Inner Ear Schwannomas With and Without Simultaneous Tumor Resection.
Objectives: Describe a single institution's cochlear implant outcomes for patients with inner ear schwannomas (IES) in the setting of various tumor management strategies (observation, surgical resection, or stereotactic radiosurgery [SRS]).
Study design: Single-institution retrospective review.
Patients: Patients diagnosed with isolated, sporadic IES who underwent cochlear implantation (CI).
Interventions: CI with or without IES treatment.
Main outcome measures: Speech perception outcomes, tumor status.
Results: Twelve patients with IES underwent CI with a median audiologic and radiologic follow-up of 12 months. Six patients underwent complete resection of the tumor at the time of CI, four underwent tumor observation, and two underwent SRS before CI. At 1 year after CI for all patients, the median consonant-nucleus-consonant (CNC) word score was 55% (interquartile range, 44-73%), and the median AzBio sentence in quiet score was 77% (interquartile range, 68-93%). Overall, those with surgical resection performed similarly to those with tumor observation (CNC 58 versus 61%; AzBio in quiet 74 versus 91%, respectively). Patients who underwent tumor resection before implantation had a wider range of speech performance outcomes compared with patients who underwent tumor observation. Two patients had SRS treatment before CI (10 months previous and same-day as CI) with CNC word scores of 6 and 40%, respectively.
Conclusions: Patients with IES who underwent CI demonstrated similar speech performance outcomes (CNC 56% and AzBio 82%), when compared with the general cochlear implant population. Patients who underwent either tumor observation or surgical resection performed well after CI.
期刊介绍:
Otology & Neurotology publishes original articles relating to both clinical and basic science aspects of otology, neurotology, and cranial base surgery. As the foremost journal in its field, it has become the favored place for publishing the best of new science relating to the human ear and its diseases. The broadly international character of its contributing authors, editorial board, and readership provides the Journal its decidedly global perspective.